Neurovive Pharmaceutical AB operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Neurovive Pharmaceutical AB with three other
miscellaneous service companies in Europe:
sales of 16,886.00 Euro [US$18,951.66 ]
(27,000.00 Norwegian Kroner [US$3,143.61 ]
Gala Pharmaceutical Inc
based in the United Kingdom
(£3,497.09 [US$4,349.61 ]
Sales fell dramatically in 2018:
During the year ended December of 2018, sales at
Neurovive Pharmaceutical AB were SEK 5,000.00 (US$533.80).
decrease of 81.5%
versus 2017, when the company's sales were SEK 27,000.00 .